Join Growin Stock Community!

Zepp health corporationZEPP.US Overview

US StockTechnology
(No presentation for ZEPP)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ZEPP AI Insights

ZEPP Overall Performance

ZEPP AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ZEPP Recent Performance

0.36%

Zepp health corporation

0.66%

Avg of Sector

-0.31%

S&P500

ZEPP PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ZEPP Key Information

ZEPP Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

ZEPP Profile

Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

Price of ZEPP

ZEPP FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.61
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.21
PB Ratio
1.40
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
37.17%
Net Margin
-28.28%
Revenue Growth (YoY)
12.54%
Profit Growth (YoY)
11.78%
3-Year Revenue Growth
-23.43%
3-Year Profit Growth
-3.61%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-4.61
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.21
PB Ratio
1.40
Price-to-FCF
-
Gross Margin
37.17%
Net Margin
-28.28%
Revenue Growth (YoY)
12.54%
Profit Growth (YoY)
11.78%
3-Year Revenue Growth
-23.43%
3-Year Profit Growth
-3.61%
  • When is ZEPP's latest earnings report released?

    The most recent financial report for Zepp health corporation (ZEPP) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ZEPP's short-term business performance and financial health. For the latest updates on ZEPP's earnings releases, visit this page regularly.

  • What is the operating profit of ZEPP?

    According to the latest financial report, Zepp health corporation (ZEPP) reported an Operating Profit of -884K with an Operating Margin of -1.17% this period, representing a growth of 92.95% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ZEPP's revenue growth?

    In the latest financial report, Zepp health corporation (ZEPP) announced revenue of 75.79M, with a Year-Over-Year growth rate of 78.49%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does ZEPP have?

    As of the end of the reporting period, Zepp health corporation (ZEPP) had total debt of 210.3M, with a debt ratio of 0.36. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does ZEPP have?

    At the end of the period, Zepp health corporation (ZEPP) held Total Cash and Cash Equivalents of 102.56M, accounting for 0.17 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ZEPP go with three margins increasing?

    In the latest report, Zepp health corporation (ZEPP) did not achieve the “three margins increasing” benchmark, with a gross margin of 38.2%%, operating margin of -1.17%%, and net margin of -2.1%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ZEPP's profit trajectory and future growth potential.

  • Is ZEPP's EPS continuing to grow?

    According to the past four quarterly reports, Zepp health corporation (ZEPP)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.16. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What are the PEG ratio and PE ratio of ZEPP?

    The latest valuation data shows Zepp health corporation (ZEPP) has a Price-To-Earnings (PE) ratio of -8.35 and a Price/Earnings-To-Growth (PEG) ratio of 0.23. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.

ZEPP Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1